THREAD: @iampinkywebb speaks to Sinovac Biotech General Manager Helen Yang on #TheSource | LIVE https://t.co/9vB0Rjs8f8

• Senators question gov't deal with China's COVID-19 vaccine, Sinovac
• Palace: Sinovac price not far from ₱650
• Why should Filipinos consider getting it?

Sinovac Biotech on vaccine deal with PH gov't: We are finalizing the term sheet. It's a non-binding understanding between the buyers and sellers.

Sinovac Biotech adds the deal is not yet sealed.
Sinovac Biotech: FDA should approve the vaccine first
Sinovac Biotech says they have already started producing the vaccine in commercial size late last year
Sinovac Biotech on cost of vaccine: Buying the vaccine is only one factor. Logistics and other factors should also be considered.
Sinovac Biotech on cost of vaccine: We gave a very good price for the Philippines
Sinovac Biotech refuses to comment on the cost of its vaccine, but says it's not among the expensive vaccines.

"The pricing is reasonable," General Manager Helen Yang says.
RELATED: Presidential Spokesperson Harry Roque said Sinovac's CoronaVac is priced near ₱650 per dose or ₱1300 for the complete two doses https://t.co/QvvMVC3uqf
Sinovac Biotech: Clinical phase 3 trials being conducted in Indonesia, Brazil, Turkey
Sinovac Biotech says the vaccine can protect people from severe cases of infection
Sinovac Biotech: We think efficacy rating will be higher among general population
Sinovac Biotech: Our safety profile is very good. The pain, as reported by our partners in other countries, was felt by around 20% of people when they were injected.
Sinovac Biotech: We're willing to supply additional documents required by FDA for emergency use authorization (EUA)
RELATED: Sinovac applied for EUA on Wednesday, but submitted incomplete documents, FDA Director General Domingo says https://t.co/YD032AGh27
Sinovac Biotech: 8 million doses of our vaccine have been rolled out in China

More from World

A quick thread on #Myitsone dam & #MyanmarChinaRelations in light of the SAC announcement that they would be restarting some stalled Chinese projects in Burma. This announcement has led to speculation about Myitsone, which has been suspended since 2011. Let’s go! ➡️ China has


consistently misunderstood & underestimated popular opposition to Myitsone. First and foremost, to the Burmese people, this is about the “mother river” of Burma - the Irrawaddy- and it’s nearly sacred importance to them as a lifeline of their country. This is what drove the

organic anti-dam movement that started locally in Kachin but +/- 2007 was effectively picked up & nationalized by Burmese environmental CSOs. Instead of understanding this, the Chinese lashed out and blamed the United States when Thein Sein suspended the project. I assure you

the USG was as surprised as China when the project was suspended. But China never believed it was truly the desire of the Burmese people that stopped the project. Today, the dam doesn’t make sense economically for Beijing & will definitely alienate Burmese, yet they stubbornly

continue to push it. Why? Let’s unpack a bit further. In addition to Myitsone, there were other campaigns & protests targeting Chinese projects such as Letpadaung copper mine & Kyaukphyu pipeline, port & SEZ. While these campaigns had varying levels off effect, none was as

You May Also Like

“We don’t negotiate salaries” is a negotiation tactic.

Always. No, your company is not an exception.

A tactic I don’t appreciate at all because of how unfairly it penalizes low-leverage, junior employees, and those loyal enough not to question it, but that’s negotiation for you after all. Weaponized information asymmetry.

Listen to Aditya


And by the way, you should never be worried that an offer would be withdrawn if you politely negotiate.

I have seen this happen *extremely* rarely, mostly to women, and anyway is a giant red flag. It suggests you probably didn’t want to work there.

You wish there was no negotiating so it would all be more fair? I feel you, but it’s not happening.

Instead, negotiate hard, use your privilege, and then go and share numbers with your underrepresented and underpaid colleagues. […]